DNSP-11 (Dopamine Neuron Stimulating Peptide-11)

GDNF-Derived Peptide · Dopaminergic Neuroprotection

Research use onlyGBP reference pricing where listedUK dispatch on catalogue items

Overview

DNSP-11 is an 11-amino acid peptide derived from the pro-domain of glial cell line-derived neurotrophic factor (GDNF). It was capture the neuroprotective properties of GDNF while avoiding the limitations of the full-length protein, including poor blood-brain barrier penetration, off-target effects, and manufacturing…

DNSP-11 acts on dopaminergic neurons through mechanisms distinct from full-length GDNF. Rather than binding to the canonical GFRalpha1/RET receptor complex, DNSP-11 appears to engage alternative signaling pathways to promote dopaminergic neuron survival, stimulate dopamine release, and protect against…

Protects dopamine-producing neurons from neurotoxin-induced damage in preclinical Parkinson's disease models.

Upregulates tyrosine hydroxylase expression, supporting the rate-limiting step in dopamine biosynthesis.

Supports mitochondrial health in dopaminergic neurons, which is often compromised in neurodegenerative conditions.

Mechanism

Protects dopamine-producing neurons from neurotoxin-induced damage in preclinical Parkinson's disease models.

Research areas

DNSP-11 is an 11-amino acid peptide derived from the pro-domain of glial cell line-derived neurotrophic factor (GDNF). It was capture the neuroprotective properties of GDNF while avoiding the limitations of the full-length protein, including poor blood-brain barrier penetration, off-target effects, and manufacturing…
DNSP-11 acts on dopaminergic neurons through mechanisms distinct from full-length GDNF. Rather than binding to the canonical GFRalpha1/RET receptor complex, DNSP-11 appears to engage alternative signaling pathways to promote dopaminergic neuron survival, stimulate dopamine release, and protect against…
Protects dopamine-producing neurons from neurotoxin-induced damage in preclinical Parkinson's disease models.
Upregulates tyrosine hydroxylase expression, supporting the rate-limiting step in dopamine biosynthesis.
Supports mitochondrial health in dopaminergic neurons, which is often compromised in neurodegenerative conditions.

Research notes

Nasal irritation or mild burning sensation (intranasal route)
Injection site reactions such as redness or swelling (subcutaneous route)
Severe or persistent nasal irritation or bleeding
Signs of allergic reaction (rash, swelling, difficulty breathing)
Unusual neurological symptoms (tremor, involuntary movements)

References

Questions

Is DNSP-11 easier to use than full-length GDNF protein?

Yes, DNSP-11 is an 11-amino acid peptide fragment of GDNF's pro-domain that offers several advantages over full-length GDNF: better blood-brain barrier penetration, avoidance of off-target effects, simpler manufacturing, and intranasal administration feasibility. It captures neuroprotective benefits while being more…

Can DNSP-11 improve baseline motivation and dopamine levels in healthy people?

Anecdotal reports from biohackers suggest DNSP-11 improves baseline motivation, drive, and mood stability in healthy individuals. These effects likely result from dopaminergic neuron support via tyrosine hydroxylase upregulation, though formal human studies on motivation/drive in non-disease populations are lacking.

What's the best way to administer DNSP-11—nasal or injectable?

Intranasal appears most popular in biohacking communities as it offers potential direct CNS delivery via olfactory transport, bypassing the blood-brain barrier. Subcutaneous injection provides reliable systemic absorption but relies on BBB penetration. Nasal administration is more convenient but may cause irritation…

How long can DNSP-11 be used continuously, or does it need cycling?

Human data on cycling versus continuous use is extremely limited. Most protocols use 4-6 week cycles followed by breaks, though DNSP-11's neurotrophic mechanism differs from stimulants that cause tolerance. Conservative approach suggests cycling to prevent potential receptor desensitization, though long-term effects…